Advice

In the absence of a submission from the holder of the marketing authorisation:        

diclofenac 4% spray gel (Mobigel Spray ®): is not recommended for use in NHSScotland.                               

Indication under review:  for the local symptomatic relief of mild to moderate pain and inflammation following acute blunt trauma of small and medium-sized joints and periarticular structures.

The holder of the marketing authorisation has not made a submission to SMC regarding this product in this indication.  As a result we cannot recommend its use within NHSScotland.

Download detailed advice69KB (PDF)

Download

Medicine details

Medicine name:
diclofenac (Mobigel Spray)
SMC ID:
667/10
Indication:
For the local symptomatic relief of mild to moderate pain and inflammation following acute blunt trauma of small and medium-sized joints and periarticular structures
Pharmaceutical company
Goldshield Pharmaceuticals Limited
BNF chapter
Musculoskeletal and joint diseases
Submission type
Non submission
Status
Not recommended
Date advice published
13 December 2010